Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 14/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.64 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27918427 | 0.97 | PTGS2 (0.67) | PTGS2PTGS1 | |
| SCHEMBL7395459 | 0.93 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL6470141 | 0.93 | PTGS2 (0.74) | PTGS2PTGS1 | |
| SCHEMBL7938593 | 0.93 | PTGS2 (0.62) | PTGS2PTGS1 | |
| SCHEMBL4278822 | 0.89 | PTGS2 (0.58) | PTGS2PTGS1 | |
| SCHEMBL17439304 | 0.87 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL7935589 | 0.87 | PTGS2 (0.56) | PTGS2PTGS1 | |
| SCHEMBL5698418 | 0.87 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL7363510 | 0.87 | SOS1 (0.66) | PTGS2PTGS1 | |
| SCHEMBL16052791 | 0.87 | PTGS2 (0.64) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12537221-B2 | Electrolyte for secondary battery and secondary battery including the same | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-01-27 | — | — | US | claimed |
| CN-119944075-A | Deep eutectic electrolyte based on phenylmethylsulfone and fluorine substituted derivatives thereof, preparation method thereof and lithium battery | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 2025-05-06 | — | — | CN | claimed |
| CN-118763273-A | Sulfonyl deep eutectic polymer electrolyte and preparation and application thereof | 青岛赛锂达储能产业技术研究院有限公司 | 2024-10-11 | — | — | CN | claimed |
| US-20220407116-A1 | ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY INCLUDING THE SAME | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-12-22 | — | — | US | claimed |
| CN-115084655-A | Electrolyte, preparation method thereof and lithium metal battery containing electrolyte | 蜂巢能源科技(无锡)有限公司 | 2022-09-20 | — | — | CN | claimed |
| US-20150164854-A1 | FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF | PHARMACYCLICS LLC | 2015-06-18 | — | — | US | claimed |
| WO-2013066833-A1 | COMPOUNDS AND METHODS TO INHIBIT HISTONE DEACETYLASE (HDAC) ENZYMES | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | claimed |
| US-20110021528-A1 | NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS | PHARMACYCLICS, INC. (US) | 2011-01-27 | — | — | US | claimed |
| WO-2010123507-A1 | TREATMENT OF NON-LOCALIZED INFLAMMATION WITH PAN-HDAC INHIBITORS | PHARMACYCLICS, INC. (US) | 2010-10-28 | — | — | WO | claimed |
| US-20100236924-A1 | LIQUID ELECTROLYTE COMPOSITION AND ITS USE IN GAS SENSORS | LIFE SAFETY DISTRIBUTION AG (CH) | 2010-09-23 | — | — | US | claimed |
| US-20040167349-A1 | Novel process for preparing rac-bicalutamide and its intermediates | TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) | 2004-08-26 | — | — | US | claimed |
| US-6737550-B2 | LITHIUM SALT OF 4- FLUOROPHENYL METHYL SULFONE AS THE CHEMICAL INTERMEDIATE; DRUG WITH ANTIANDROGEN ACTIVITY | BIOGAL GRYOGYSZERGYAR RT. (HU) | 2004-05-18 | — | — | US | claimed |
| EP-1406855-A2 | NOVEL PROCESS FOR PREPARING RAC-BICALUTAMIDE AND ITS INTERMEDIATES | BIOGAL GYOGYSZERGYAR RT. (HU) | 2004-04-14 | — | — | EP | claimed |
| US-20040059147-A1 | Novel process for preparing rac-bicalutamide and its intermediates | TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) | 2004-03-25 | — | — | US | claimed |
| US-20030045741-A1 | Novel process for preparing rac-bicalutamide and its intermediates | TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG (HU) | 2003-03-06 | — | — | US | claimed |
| WO-2002100339-A2 | NOVEL PROCESS FOR PREPARING RAC-BICALUTAMIDE AND ITS INTERMEDIATES | BIOGAL GYOGYSZERGYAR RT. (HU) | 2002-12-19 | — | — | WO | claimed |
| US-5897940-A | Ink jet transparencies | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| US-5744273-A | Laminatable backing substrates containing fluoro compounds for improved toner flow | XEROX CORPORATION (US) | 1998-04-28 | — | — | US | claimed |
| US-4921941-A | TRIPEPTIDE ESTERS | SCHERING CORPORATION (US) | 1990-05-01 | — | — | US | claimed |
| WO-1989000165-A1 | ORALLY ACTIVE ANTIANDROGENS | SCHERING CORPORATION (US) | 1989-01-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040059147-A1 | Novel process for preparing rac-bicalutamide and its intermediates | RAC2, RAC3, RAC1 | PTGS2 2447/4885PTGS1 2713/4885ENPP2 1538/4885 |
| US-20150164854-A1 | FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR AND USES THEROF | HDAC1, HDAC2, HDAC8 | PTGS2 4003/4885PTGS1 4117/4885ENPP2 3338/4885 |
| US-12537221-B2 | Electrolyte for secondary battery and secondary battery including the same | NCS1, KCNN2, SLC9A1 | PTGS2 4197/4885PTGS1 4138/4885ENPP2 4847/4885 |
| US-20030045741-A1 | Novel process for preparing rac-bicalutamide and its intermediates | RAC2, RAC3, RAC1 | PTGS2 2447/4885PTGS1 2713/4885ENPP2 1538/4885 |
| US-20110021528-A1 | NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS | HDAC1, HDAC3, HDAC5 | PTGS2 2220/4885PTGS1 1439/4885ENPP2 1117/4885 |
| US-20040167349-A1 | Novel process for preparing rac-bicalutamide and its intermediates | RAC2, RAC3, RAC1 | PTGS2 2447/4885PTGS1 2713/4885ENPP2 1538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.